NXN
Basic information
Region (hg38): 17:799310-979776
Links
Phenotypes
GenCC
Source:
- robinow syndrome, autosomal recessive 2 (Limited), mode of inheritance: AR
- autosomal recessive Robinow syndrome (Supportive), mode of inheritance: AR
- robinow syndrome, autosomal recessive 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Robinow syndrome, autosomal recessive 2 | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal | 29276006 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Robinow syndrome, autosomal recessive 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NXN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 51 | 10 | 61 | |||
missense | 54 | 56 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 7 | 3 | 11 | ||
non coding | 28 | 31 | 59 | |||
Total | 3 | 1 | 55 | 80 | 42 |
Variants in NXN
This is a list of pathogenic ClinVar variants found in the NXN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-800777-A-G | Benign (May 14, 2021) | |||
17-800802-T-G | Benign (May 14, 2021) | |||
17-800947-C-T | NXN-related disorder | Likely benign (Jun 27, 2019) | ||
17-800958-C-T | Likely benign (Sep 10, 2023) | |||
17-800961-C-T | Benign (Jan 29, 2024) | |||
17-801000-C-G | Uncertain significance (Jun 13, 2022) | |||
17-801001-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
17-801006-G-A | Likely benign (Oct 01, 2023) | |||
17-801020-TCTC-T | Robinow syndrome, autosomal recessive 2 | Pathogenic (Aug 08, 2019) | ||
17-801024-C-G | not specified | Uncertain significance (Jul 28, 2021) | ||
17-801027-C-T | Likely benign (Jan 11, 2022) | |||
17-801039-G-A | NXN-related disorder | Likely benign (Aug 17, 2023) | ||
17-801072-G-A | Likely benign (Oct 05, 2023) | |||
17-801083-C-A | Uncertain significance (Aug 31, 2021) | |||
17-801095-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
17-801102-G-A | Likely benign (Apr 04, 2022) | |||
17-801140-G-A | Likely benign (Jun 11, 2023) | |||
17-801240-C-A | Benign (May 14, 2021) | |||
17-801260-G-T | Benign (May 15, 2021) | |||
17-803622-G-C | Benign (May 14, 2021) | |||
17-803673-C-T | NXN-related disorder | Likely benign (Jan 24, 2024) | ||
17-803674-G-A | NXN-related disorder | Benign (Dec 17, 2023) | ||
17-803675-C-T | Likely benign (Aug 12, 2022) | |||
17-803675-C-CA | Likely benign (Jan 03, 2023) | |||
17-803687-C-T | not specified | Uncertain significance (Jul 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NXN | protein_coding | protein_coding | ENST00000336868 | 8 | 180458 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00275 | 125728 | 0 | 4 | 125732 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.18 | 155 | 252 | 0.614 | 0.0000162 | 2779 |
Missense in Polyphen | 41 | 81.159 | 0.50518 | 890 | ||
Synonymous | 0.922 | 101 | 113 | 0.890 | 0.00000778 | 892 |
Loss of Function | 4.12 | 1 | 21.7 | 0.0460 | 0.00000125 | 221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000515 | 0.0000462 |
European (Non-Finnish) | 0.0000186 | 0.0000176 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a redox-dependent negative regulator of the Wnt signaling pathway, possibly by preventing ubiquitination of DVL3 by the BCR(KLHL12) complex. May also function as a transcriptional regulator act as a regulator of protein phosphatase 2A (PP2A) (By similarity). {ECO:0000250}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.0963
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.77
Haploinsufficiency Scores
- pHI
- 0.294
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.881
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nxn
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; skeleton phenotype; immune system phenotype;
Gene ontology
- Biological process
- Wnt signaling pathway;cell differentiation;negative regulation of Wnt signaling pathway;negative regulation of protein ubiquitination;cell redox homeostasis;oxidation-reduction process;cardiovascular system development;cellular oxidant detoxification
- Cellular component
- nucleus;cytosol
- Molecular function
- thioredoxin-disulfide reductase activity;protein-disulfide reductase activity